IL-18 serum levels might be considered a prognostic factor for patients with gastric cancer [50], where it was highlighted that patients with this type of tumor and increased IL-18 serum levels present a lower survival rate when compared with patients with the same condition but lower levels of circulating IL-18 (Table 1). The gene discussed is IL18; the disease is gastric cancer.